Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lepu Hengjiuyuan Pharmaceutical is a Chinese pharmaceutical company specializing in the development, production, and sale of cardiovascular medications. As a core subsidiary of Lepu Medical, the company serves as a major manufacturing base for essential generic drugs, including Clopidogrel Bisulfate and Atorvastatin Calcium. Its product portfolio primarily targets chronic conditions such as hypertension, hyperlipidemia, and thrombosis, supporting Lepu Medical's integrated healthcare strategy. The company operates large-scale GMP-certified facilities in Henan Province and has successfully passed consistency evaluations for several key products. Lepu Hengjiuyuan plays a critical role in providing affordable cardiovascular therapies within the Chinese hospital and retail pharmacy markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 乐普恒久远药业.